Portal de Periódicos da CAPES

Knick-knack PADIMAC

2018; Elsevier BV; Volume: 132; Issue: 20 Linguagem: Inglês

10.1182/blood-2018-10-875138

1528-0020

Brian A. Walker,

Chronic Lymphocytic Leukemia Research

In this issue of Blood , Chapman et al 1 have derived a 7-gene expression signature that predicts whether a newly diagnosed myeloma patient will respond to treatment with bortezomib when autologous stem cell transplant (ASCT) is not considered as part of the upfront therapy.